Tobacco Smoking and Psychotic-Like Experiences in a General Population Sample
Overview
Affiliations
Objective: Recent findings suggest an association between tobacco and psychosis, but whether this association is mediated by confounding factors is unknown. Psychosis-like experiences (PLEs) are a subclinical expression of psychosis. To disentangle the association of tobacco with PLEs, we examined data from a large US population-based, nationally representative sample.
Methods: Analysis was conducted on Wave 2 of the National Epidemiologic Survey of Alcohol and Related Conditions (N = 34,653 adults, conducted from 2004 to 2005). Participants were assessed with the Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV. Twenty-two PLEs previously described as observed indicators of psychosis were used. Participants were stratified according to their smoking status (never/former/current) for 5 different types of tobacco.
Results: There was a significant association (ie, with 95% CIs for which the lower value was ≥ 1) between smoking status and 14 of the 22 assessed PLEs. These associations remained significant after adjustment for sociodemographic variables (including urbanicity or ethnicity), lifetime drug use disorder, and past-year cannabis use. While 26.33% of nonsmokers reported at least 1 PLE, this prevalence was slightly higher in former smokers (27.48%) and rose as high as 39.09% in current smokers (for current smokers vs lifetime abstainers, adjusted OR = 1.33; 95% CI, 1.23-1.45). All 22 PLEs had higher prevalence in smokers than in former smokers or lifetime abstainers. A total of 8.56% of smokers reported at least 5 PLEs, compared to 3.42% in lifetime abstainers (aOR = 1.56; 95% CI, 1.32-1.84).
Conclusions: In a large population-based, nationally representative sample, smoking status was associated with various PLEs. This association was not explained only by other known risk factors of PLEs or schizophrenia. There is a need to identify the potential neurobiological mechanisms by which smoking and PLEs are associated, for patients and from a public health perspective.
Xu B, Chen C, Wang D Psychol Res Behav Manag. 2024; 17:799-811.
PMID: 38434958 PMC: 10908336. DOI: 10.2147/PRBM.S451889.
Johnstad P Front Public Health. 2024; 11:1268339.
PMID: 38249418 PMC: 10797041. DOI: 10.3389/fpubh.2023.1268339.
Schirmbeck F, van der Ven E, Boyette L, McGuire P, Valmaggia L, Kempton M Front Psychiatry. 2022; 13:869023.
PMID: 35942478 PMC: 9356251. DOI: 10.3389/fpsyt.2022.869023.
Marchi M, Elkrief L, Alkema A, van Gastel W, Schubart C, van Eijk K Transl Psychiatry. 2022; 12(1):219.
PMID: 35650188 PMC: 9160238. DOI: 10.1038/s41398-022-01975-1.
Yilmaz Kafali H, Turan S, Akpinar S, Mutlu M, Ozkaya Parlakay A, Cop E Schizophr Res. 2022; 241:36-43.
PMID: 35074530 PMC: 8730741. DOI: 10.1016/j.schres.2021.12.049.